SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Verkaylac who wrote (59)9/25/1997 5:20:00 PM
From: Bob Davis  Read Replies (1) of 315
 
The most recent "Update" issue of The Napeague Letter, which was
e-mailed to subscribers last Sunday evening, contained the following
comments:

Candela Corporation (NASDAQ:CLZR)
For reasons unknown, CLZR has spurted from around $4.50 at the
beginning of September, to over $6.00 during the middle of last week.
I do not know what caused this to happen; the stock has not gained
additional analyst coverage, and the move was not accompanied by a
consistent increase in volume.

I think it is important to remember that the next several months will
probably see the Company releasing more "bad news". Their Report
10-K should be filed with the SEC in the next week or two, and it will
detail the problems that led to the fourth quarter shortfall. Then, the
Company should release its first quarter results in late October, and I
expect that these results will also be weak. I think that this move will
be short-lived.

An in-depth Analysis of CLZR can be found on the Napeague web site
at napeague.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext